Producing a successful malaria vaccine: innovation in the lab and beyond.

Health Aff (Millwood)

PATH Malaria Vaccine Initiative, in Washington, DC, USA.

Published: June 2011

With approximately 225 million new cases and 800,000 deaths annually, malaria exacts a tremendous toll--mostly on African children under the age of five. Late-stage trials of an advanced malaria vaccine candidate--which, if approved, would become the world's first malaria vaccine--are under way, and it may be ready for use by 2015. This article recounts the pivotal roles in that achievement played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine. Just as it takes a village to raise a child, it has taken a huge number of stakeholders around the world to reach this point. Developing even more effective vaccines for malaria and other diseases will require continued hard work and creative thinking from scientists, regulators, and policy makers.

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2011.0356DOI Listing

Publication Analysis

Top Keywords

malaria vaccine
8
malaria
5
producing successful
4
successful malaria
4
vaccine innovation
4
innovation lab
4
lab 225
4
225 cases
4
cases 800000
4
800000 deaths
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!